2022-02-28 |
1 |
Complaint |
them. The Asserted Patents are among them:
a. U.S. Patent No. 8,058,069, “Lipid Formulations…deliver nucleic acid-based medicines: U.S. Patent Nos. 8,058,069 (Exhibit A), 8,492,359
(Exhibit B), 8,822,668… COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069
65. Paragraphs 1 through 64…Arbutus’s U.S.
Patent No. 9,404,127 (“the ’127 Patent”), which, like the Asserted Patents, is directed …attempted to invalidate several of the patents before the United States Patent
Case 1:22-cv-00252-MSG Document |
External link to document |
2023-08-29 |
129 |
Claim Construction Chart |
the six patents that Plaintiffs have asserted Defendants infringe: U.S. Patent Nos. 8,058,069 (the
“’…Petition for Inter Partes Review of U.S. Patent No.
8,058,069, IPR2019-00554 (Jan. 9, 2019)
Petitioner…Petition for Inter Partes
Review of U.S. Patent No. 8,058,069, IPR2019-00554,
Exhibit 1008 (Jan. 2, 2019…Petition for Inter Partes Review of U.S. Patent No. 8,058,069,
IPR2019-00554 (Jan. 9, 2019)
Petitioner…Petition for Inter Partes Review of U.S. Patent
No. 8,058,069, IPR2019-00554, Exhibit 1008, (Jan. 2, 2019 |
External link to document |
2023-09-27 |
133 |
|
COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069
65. Paragraphs 1 through …attempted to invalidate several of the patents before the United States Patent
Case
Case
1:22-cv-00252-…Arbutus’s patented technology, including the technology described and claimed in the
Asserted Patents. Moderna…The United States Patent and Trademark Office duly and legally issued the ’069
Patent to one of Arbutus…incorporating
Arbutus’s patented LNP delivery technology covered by the ’069 Patent, without authority or |
External link to document |